News Headlines

  1. FDA Approves TraceLink DSCSA Pilot Submission For Network Solutions; Delivering 2023 Traceability By Leveraging Blockchain And Digital Recalls Across A Supply Network

    TraceLink Inc., the world’s largest integrated digital supply network providing real-time information sharing for better patient outcomes, recently announced the acceptance of its participation in the Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).

  2. Pelican BioThermal To Present Development Of Laboratory Mechanical Testing Protocol For Reusable Thermal Packaging At ISTA Forum

    Pelican BioThermal, the global name in temperature-controlled packaging, is testing the durability of reusable parcel thermal packaging systems based on average repeated use.

  3. LSNE Announces GMP Certification By Brazil's ANVISA

    Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization (CDMO) specializing in pharmaceuticals and medical devices, announced today that it has received Good Manufacturing Practices (GMP) certification from Brazil's National Health Surveillance Agency - ANVISA (Agência Nacional de Vigilância Sanitária) following an inspection and audit of its manufacturing facility in Manchester, NH in February 2019.

  4. CPhi Expert Forecasts ‘Huge Growth In Middle East Manufacturing With Europe A Medium-Term Target’

    CPhI Middle East & Africa (CPhI MEA) expert Madhukar Tanna, Chief Executive Officer of Pharmax, a United Arab Emirates (UAE) based branded generic manufacturer, says favourable conditions in the UAE are resulting in a boom of pharmaceutical manufacturing throughout the region.

  5. Vibalogics Increases Capacity With A New 200L Line For Virus Manufacturing

    GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.

  6. Recipharm Launches Recipharm Inhalation Solutions As Its End-To-End Offering For Inhalation Products

    Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.

  7. See The Latest Generation Of Award-Winning Golden Hour™ Technology — A Smaller, Lighter Reusable Container For Transporting Blood To The Battlefield

     Pelican BioThermal, the global name in temperature controlled packaging, will display its new Golden Hour™ One at the 2019 SOMSA conference from May 8 – 9 in Charlotte, North Carolina in booth #602P.

  8. Research Point Global And WuXi CDS To Rebrand As WuXi Clinical – A Client-Centric CRO – At DIA 2019

    The mid-sized CRO market has seen a number of significant changes, and now the recently merged Research Point Global (RPG) and WuXi Clinical Development Services (CDS) are to rebrand as WuXi Clinical at DIA 2019. The event, held this year in San Diego, is widely seen by the industry as a key point in the CRO calendar at which major developments are announced, and with more of the drug pipeline emerging from small and mid-sized pharma, much attention has this year focused upon middle-tier CROs.

  9. Dalton Pharma Services Successfully Completes Its First FDA Pre-Approval Inspection Of Its Canadian Manufacturing Facility

    Dalton Pharma Services announced that the US Food and Drug Administration (FDA) completed a PAI inspection of its Health-Canada licensed manufacturing facility in Canada, in January 2019.

  10. Merck & Co. Announces $1.2B Restructuring Plan

    Merck & Co. has approved a new global restructuring program, at a cost of $800M to $1.2B, as part of a global initiative focused primarily on further optimizing the company’s manufacturing and supply network as well as reducing its global real estate footprint.